Compare · head to head
Sarepta Therapeutics vs Suncor
Suncor ranks higher overall — 360 rank 95 vs 69.
Sarepta Therapeutics leads on Value (64 vs 57) and Sentiment (50 vs 41). Suncor leads on Growth (64 vs 46) and Safety (73 vs 40). The two are close on Quality.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | Canada |
| Sector | Health Care | Energy & Oil |
| Industry | Biotechnology | Oil, Gas & Consumable Fuels |
| Size | Large | Large |
| ISIN | US8036071004 | CA8672241079 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 69 | 95 |
| Value | 64 | 57 |
| Quality | 70 | 70 |
| Growth | 46 | 64 |
| Safety | 40 | 73 |
| Sentiment | 50 | 41 |
| Quality details | ||
| Profitability | 75 | 74 |
| Cash Truth | 64 | 66 |
Sarepta Therapeutics vs PTC TherapeuticsSarepta Therapeutics vs Krystal BiotechSarepta Therapeutics vs Xeris PharmaceuticalsSarepta Therapeutics vs Tarsus PharmaceuticalsAdd a third stock →
Full analyses: Sarepta Therapeutics · Suncor
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100